Exhibit 10.3

 

January 27, 2003

 

 

Dr. Krishnan Nandabalan

Vice President, Alliances

Genaissance Pharmaceuticals, Inc.

5 Science Park

New Haven, CT 06511

 

 

Dear Dr. Nandabalan,

 

Further to our recent discussions regarding the Agreement between Pfizer Inc and
Genaissance Pharmaceuticals, Inc. dated August 31, 2001 (“2001 Agreement”);
Pfizer Inc (“Pfizer”) and Genaissance Pharmaceuticals, Inc. (“Genaissance”) will
amend the 2001 Agreement as follows:

 

Section 3 is replaced in its entirety with the following text:

 

Section 3     Term:  The term of this Agreement is three (3) years from August
31, 2001.

 

All other terms and conditions of the 2001 Agreement shall remain unchanged and
in full force.

 

Please have the appropriate official of Genaissance Pharmaceuticals, Inc. sign
both copies of this Agreement and return one original to Kelly P. Longo at the
above address.

 

 

Sincerely,

               
/s/ Mark P. DellaPorta

Mark P. DellaPorta

Site Director

Strategic Alliances

 

 

Agreed:

 

Genaissance Pharmaceuticals, Inc.

 

 

By:

/s/ Krishnan Nandabalan

 

 

Date: February 6, 2003

 

 

--------------------------------------------------------------------------------